3,5-Dihydro-imidazo[4,5-d]pyridazin-4-ones: A class of potent DPP-4 inhibitors
Matthias Eckhardt(University of Bonn), Ralf Lotz(Boehringer Ingelheim (Germany)), Herbert Nar(Boehringer Ingelheim (Germany)), Leo Thomas(Boehringer Ingelheim (Germany)), Frank Himmelsbach(Boehringer Ingelheim (Germany)), Norbert Hauel(Boehringer Ingelheim (Germany)), Michael Mark(Boehringer Ingelheim (Germany)), Elke Langkopf(Boehringer Ingelheim (Germany)), Brian D. Guth(Boehringer Ingelheim (Germany)), Moh Tadayyon(Boehringer Ingelheim (Germany))
Cited by 40
Related Papers
Crystal structure analysis of oxidized Pseudomonas aeruginosa azurin at pH 5·5 and pH 9·0
|Journal of Molecular Biology|1991|487
Structure-Based Design of Novel Potent Nonpeptide Thrombin Inhibitors
|Journal of Medicinal Chemistry|2002|454
Biophysics in drug discovery: impact, challenges and opportunities
|Nature Reviews Drug Discovery|2016|383
Adult Ceramide Synthase 2 (CERS2)-deficient Mice Exhibit Myelin Sheath Defects, Cerebellar Degeneration, and Hepatocarcinomas
|Journal of Biological Chemistry|2009|303